Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Lymphoma 1Lymphohistiocytosis, Hemophagocytic 1Hodgkin Disease 1Epstein-Barr Virus Infections 1

Interventions

Etoposide 4pegaspargase 3Cyclophosphamide 3Methylprednisolone 2Gemcitabine 2Flow Cytometry 2Dexamethasone 2Alemtuzumab 2zanubrutinib 1sintilimab 1ruxolitinib 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Vincristine 1Thiotepa 1Th1-Th2 Balance 1Tacrolimus 1Rituximab 1Prednisone 1Polymerase Chain Reaction 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Methylprednisolone Hemisuccinate 1Melphalan 1In Situ Hybridization 1Immunohistochemistry 1EPOCH protocol 1Doxorubicin 1Cytogenetic Analysis 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphohistiocytosis, Hemophagocytic × In Situ Hybridization × Lymphoid × Clear all
NCT01490801 2016-05-17

Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma

Children's Oncology Group

Completed
50 enrolled
LymphoidMyeloid

Hodgkin Disease, Lymphoma, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡